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In adult patients with congenital adrenal hyperplasia (CAH), the presence of testicular adrenal rest tumours (TART) is an impor-
tant complication leading to gonadal dysfunction and infertility. These tumours can be already found in childhood and puberty.
In this paper, we review the embryological, histological, biochemical, and clinical features of TART and discuss treatment options.
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1.Introduction
Congenital adrenal hyperplasia is an inherited disorder
aﬀecting the steroid synthesis of the adrenal gland. In more
than 90% of the cases, CAH is caused by CYP21 (21-
hydroxylase) deﬁciency [1, 2]. CYP21 deﬁciency results in an
impaired production of cortisol and mostly of aldosterone.
Consequently, pituitary ACTH production is increased lead-
ing to hyperplasia of the adrenal glands and overproduction
of adrenal androgens with prenatal virilisation of the female
external genitalia. The impaired production of cortisol and
aldosterone may lead to an Addisonian crisis with salt
wasting and dehydration in early life [1].
Nowadays, the diagnosis of the most severe types of CAH
can be made at an early age by neonatal screening programs
or by prenatal diagnosis in the case of an aﬀected proband,
thereby preventing life threatening events [3]. However, in
adult CAH patients several complications can develop and
in recent years it became clear that some of them might be
detected already in childhood. One of the most important
and frequently detected complications in male CAH patients
is the development of testicular tumours. These tumours
were ﬁrst reported in 1940 by Wilkins et al. [4]. Since then
testicular tumours have been described in several papers,
mainly case reports [5–9]. Because of the morphological and
functional resemblance with adrenal tissue they are called
“testicular adrenal rest tumours” (TART).
The reported prevalence of TART varies between 0 and
94% and depends on the selection of the patients (age,
hormonalcontrol)andthemethodoftumourdetection[10–
16]. Usually only tumours of more than 2cm are detectable
by palpation because of their location within the rete testis.
Therefore, the tumours can be easily missed when additional
imaging techniques such as ultrasound or magnetic reso-
nance imaging (MRI) are not performed. Screening of TART
is not routinely performed in male CAH patients.
2. Morphological Characteristics of TART
TART are benign tumours and in most patients the tumours
are present bilaterally. The typical location is within the rete
testis. Histologically, TART resemble adrenocortical tissue
[17–19]. The tumours are not encapsulated and consist of
sheets or conﬂuent cords of large polygonal cells with abun-
dant eosinophilic cytoplasm (Figure 1) .H o w e v e r ,ac l e a r
histological diﬀerentiation between TART and malignant
Leydig cell tumours may be diﬃcult. Some clinical features
can help to distinguish between these tumours: TART are
bilateral in more than 80%, whereas Leydig cell tumours
are bilateral in only 3% of the cases. Furthermore, Reinke2 International Journal of Pediatric Endocrinology
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Figure 1: Testicular adrenal rest tumour growing into rete testis
(RT) (HE, original magniﬁcation x 200).
crystals, which can be found in 25–40% of Leydig cell
tumours,areabsentinTART.Malignantdegenerationisseen
in 10% of Leydig cell tumours but has never been described
in patients with TART.
3.TheAetiology andFunctionalFeatures
of TART
Until now the aetiology and functional features of the
tumours are not completely understood. The clinical obser-
vation that high doses of glucocorticoids can reduce tumour
size, most probably due to suppression of ACTH secretion,
and that tumour growth may be promoted in conditions
where ACTH concentration is high, such as in poorly con-
trolled CAH patients or in patients with Nelson’s syndrome,
suggests the presence of ACTH receptors on tumour cells
[7, 8]. Therefore, it is hypothesized that TART arise from
aberrant adrenal cells descended in the embryological period
together with the testes.
A limited number of in vivo and in vitro studies showed
the presence of adrenal speciﬁc 11β-hydroxylated steroids
suchas21-deoxycorticosterone(21DB)and21-deoxycortisol
(21DF) in blood taken from the gonadal veins [20–23]. This
indicates the presence of adrenal-like tissue in the testes of
these CAH patients with 21-hydroxylase deﬁciency because
these steroids can only be synthesized by adrenal speciﬁc
11-hydroxylation, without the need of the deﬁcient 21-
hydroxylation step. Recently, we described the presence of
adrenal speciﬁc enzymes CYP11B1 and CYP11B2 as well as
of ACTH and angiotensin II (AII) receptors in 16 testicular
tumours of eight patients as measured by mRNA expression
with quantitative PCR [24]. Therefore, it can be speculated
that tumour growth in CAH patients may not only be
stimulated by elevated ACTH concentrations but also by
elevated AII levels, as present in salt-wasting CAH patients
with poor hormonal control.
Interestingly, intensifying of glucocorticoid treatment
with suppression of ACTH secretion is not always successful
in reducing tumour size and even in well-controlled CAH
patients, with normal or suppressed plasma ACTH levels,
testicular adrenal rest tumours are found [6, 25, 26]. So
most probably other unknown factors have to contribute
to tumour growth. In the literature, the presence of ectopic
adrenal rest cells in the testes or along the spermatic cord of
healthy neonates is reported with a prevalence of up to 15%,
mostly described in patients who underwent groin surgical
explorations [27, 28]. However, this prevalence is probably
underestimated because single adrenal-like cells or small cell
groups are very diﬃcult to detect. The presence of these
aberrant adrenal cells within the testis is the most probable
prerequisite for the development of TART explaining the
often observed discrepancy between the development of
TART and hormonal control. It is likely that CAH patients
without preexisting ectopic adrenal rest cells within their
testes will never develop TART.
Our observation that TART can already be detected in
early childhood even in adequately treated patients suggests
that when adrenal rest cells are present within the testis,
even mildly or intermittently increased ACTH (and AII)
concentrations may induce proliferation of these cells within
the testis. Poor hormonal control with high ACTH levels
may accelerate this process. Furthermore, adrenal cells may
already be stimulated in utero where there are elevated levels
of ACTH.
So, both the concentrations of and the duration of expo-
sure to growth promoting factors are probably important
in the pathogenesis of tumour growth. Furthermore, it can
be hypothesized that the pubertal rise of LH may give an
additional stimulation of tumour growth as LH receptors
are found in TART [29], which may explain the increased
prevalence of TART in pubertal and postpubertal CAH
patients even when there is good hormonal control. Detailed
studies focusing on the eﬀect of ACTH, AII, and LH in
young, male CAH patients are needed to determine the role
of these factors in the development of TART.
In a recent paper, Val et al. suggest that adrenal rest cells
may develop from a diﬀerent population of adrenal like cells.
They describe the presence of cells with mixed adrenal and
Leydig cell properties within the mouse testis [30]. These
cells express adrenal markers such as CYP11B1 and CYP21
and respond to ACTH and HCG incubations. Therefore,
TART may also develop from a diﬀerent population of cells
with adrenal features. Of course these ﬁndings have to be
translated with caution to the human population as mouse
fetal testes also express ACTH receptors in contrast to the
developing human testes [30].
4. Long-Term Consequences of TART
TART have no malignant features and, therefore, there seems
to be no need to remove them at an early stage. However,
because of the central localization of the tumours near the
mediastinum testis, compression of the seminiferous tubules
ﬁnally may lead to obstructive azoospermia and irreversible
damage of the surrounding testicular tissue. In a recent
study, we showed a decreased tubular diameter and a varying
degreeofperitubularﬁbrosisandtubularhyalinizationinthe
testicular biopsies of 7 male CAH patients with longstandingInternational Journal of Pediatric Endocrinology 3
Figure 2: Testicular biopsy of a patient showing seminiferous
tubules with hypospermatogenesis and prominent peritubular
ﬁbrosis with increased number of peritubular ﬁbroblasts (arrows),
as well as tubular hyalinisation (arrow-head; original magniﬁcation
x 200).
bilateral TART and clinical infertility (Figure 2)[ 17]. Fur-
thermore, we found a severe decrease in the number of germ
cells in all patients. In the literature, obstructive azoospermia
is described mainly as a result of extratesticular obstruction
due to infections or surgical interventions mostly located
at the epididymis or vas deferens [31–34]. In these cases,
adverse eﬀects of the obstruction on the germinal epithelium
or Leydig cells were not reported [32, 34]. This can be
explainedbytheabilityoftheepididymistobecomeenlarged
to accommodate the sperm cells and to phagocytise and
resorb spermatozoa [32]. It can be speculated that in the case
of large TART located in the mediastinum testis proximal to
the epididymis, the eﬀerent ﬂow in the seminiferous tubules
is chronically obstructed without having the possibility of
compensatory dilatation of the epididymis. Longstanding
obstruction of the seminiferous tubules could then lead to
hypospermatogenesis and peritubular ﬁbrosis.
In addition to the mechanical eﬀects, the tumours may
also have a paracrine eﬀect on the surrounding tissue.
Steroids produced by the tumour cells may be toxic to the
Leydig cells and/or germ cells [35].
The irreversible end stage of longstanding TART is
tubular hyalinization with obstruction of the lumen and
complete loss of germ cells and Sertoli cells. In contrast to
ischemic hyalinization, where a reduced number of Leydig
cells are expected, the interstitium of our patients contained
a normal or only slightly reduced number of Leydig cells
[17]. Therefore, TART represent a very speciﬁc cause of
obstructive azoospermia, commonly not mentioned in the
literature and with more severe clinical consequences than
other forms.
5.TART inChildhood
The presence of TART in children is described mostly in
case reports [36–38] and only a limited number of studies
describe its prevalence in larger populations of children
and adults [5, 15, 39, 40]. Avila et al. detected TART by
ultrasound in 8 of 38 male CAH patients (age 6–31 years)
[15]. The mean age of the patients was 14.8 years and 7 of the
8 patients with TART were below 18 years old. The youngest
patient was 6.2 years old. The total number of investigated
patients below 18 years of age was not reported. Vanzulli
et al. described a prevalence of 27% of TART in a group of
30 CAH patients between 9 and 32 years old [39]. In the
24-investigated patients below 18 years 7 (29%) had TART.
However, these studies did not focus on childhood age and
did not present information on gonadal function.
Shanklin et al. studied autopsy material of patients with
CAH and detected TART in 3 of 7 patients less than 8
weeks old [5]. In our own patient population, we found that
in 34 male CAH children (age 2–18 years old) TART are
already present in childhood with a prevalence of 24% [40].
The prevalence increased with age. None of the tumours
were detectable by palpation and none of the children with
testicular tumours showed signs of gonadal dysfunction. In
another study of 19 male CAH patients, age 2–10 years old, a
similar prevalence of 21% was found [41]. The investigators
found signiﬁcantly lower inhibin B values in the CAH group
compared with a healthy control group suggesting that
gonadal dysfunction is already present in prepubertal CAH
children [41].
6.ProposedClassiﬁcationof TART
Based on the histological appearance of TART and the
surrounding testicular parenchyma and the clinical obser-
vations described above, we propose that the development
and growth of TART can be divided in ﬁve diﬀerent stages
(Table 1 and Figure 3).
Stage 1. This stage can be deﬁned as the presence of adrenal
rest cells within the rete testis, not detectable by scrotal
ultrasound. In healthy boys, these cells probably regress in
utero or in the ﬁrst years of life.
Stage 2. In CAH patients, the adrenal rest cells may prolif-
erate in the presence of increased concentrations of growth
promoting factors such as ACTH (and possibly also of AII).
In this stage, the adrenal rest cells may become visible by
ultrasound as one or more small hypoechogenic lesions. The
age of onset of cell growth may depend on the cumulative
exposure to ACTH (and AII) concentrations over time and
the number of ACTH (and AII) receptors on the adrenal rest
cells.
Stage 3. Further growth of the adrenal rest cells will
compress the rete testis. In pubertal or postpubertal CAH
patients, oligo- or azoospermia may already be found due
to obstruction of the seminiferous tubules. Signs of gonadal
dysfunction such as decreased inhibin B and increased FSH
and LH levels may also be present. At this stage, tumour
size may still be reduced by high dosages of glucocorticoids.
H o w ev e r ,bec a u s ei tc a nbee x pect edt h a tt u m o u rgr o wt hwi ll
restart after decreasing the dose of glucocorticooids, this is
only a temporary solution.4 International Journal of Pediatric Endocrinology
Table 1: Proposed classiﬁcation of testicular adrenal rests.
Histological description Reversibility Treatment options
Stage 1 Presence of adrenal rests within the rete
testis—not detectable
+++ —
Stage 2
Hypertrophy and hyperplasia of adrenal rest cells
d u et og r o w t hs t i m u l a t i n gf a c t o r s( e . g . ,A C T H ,
AII)
+++ Optimizing glucocorticoids
Stage 3 Further growth of the adrenal rest cells with
(reversible) compression of the rete testis
++ Optimizing glucocorticoids
Surgery?
Stage 4 Induction of ﬁbrosis and focal lymphocytic
inﬁltrates
−/+ Surgery?
Stage 5 Irreversible damage of testicular parenchyma. − —
Parts of the tumour are replaced by adipose tissue
Stage 4. Further hypertrophy and hyperplasia of the adrenal
rest cells with progressive obstruction of the rete testis
may lead to induction of ﬁbrosis within the tumour and
focal lymphocytic inﬁltration. Several small tumours within
the rete testis will conﬂuate, forming a single-lobulated
structure separated from the residual testicular tissue by
ﬁbrous strands. In this stage, high doses of glucocorticoids
a r ep r o b a b l yn ol o n g e re ﬀective in decreasing tumour size
because parts of the tumours consist of ﬁbrous tissue and/or
becausetheadrenalrestcellsmaydediﬀerentiateintimewith
loss of ACTH and AII dependency. Furthermore, peritubular
ﬁbrosis can be found in the surrounding testicular tissue
indicating early testicular damage.
Stage 5. Chronic obstruction subsequently will lead to dest-
ruction of the surrounding testicular parenchyma with irrev-
ersible damage of the testis.
Further studies are necessary to validate this proposed
classiﬁcation of TART.
7.DiagnosisofTART(Table 2)
Because the location of the tumours within the rete testis
TART are diﬃcult to palpate, usually only tumours with
a size of more than 2cm are detectable by palpation.
Ultrasound and MRI are equally good methods for detection
and monitoring of the tumours (Figures 4 and 5), but
ultrasoundispreferablebecauseitisquickandcheap[26,42]
and even very small adrenal rests of only a few millimetres
in diameter are detectable. However, until now very small
adrenal rests or single cells (stage 1) cannot be detected
even not with radiological techniques. In stage 2, testicular
tumours can be visible as small hypoechogenic lesions.
From stage 3 onwards ﬁbrous strands can be visible as
hyperechogenic reﬂections. In our clinic, we start routinely
yearly scrotal ultrasound screening from 8 years onwards.
Evaluation of gonadal function by determining blood
LH,FSH,inhibinB,andtestosteroneconcentrationscanhelp
to determine the degree of gonadal failure as is expected
from stage 3 onwards. It should be realized that LH and FSH
are of limited value to evaluate gonadal function in CAH
Table 2: Diagnosis and follow up of TART in male patients with
congenital adrenal hyperplasia.
(i) Scrotal ultrasound 1 x/year from 8 years onwards
(ii) Biochemical analysis 1 x/year:
(1) Hormonal control: ACTH, renin,
17-hydroxyprogesterone, androstenedione
(2) Gonadal function: LH, FSH, inhibin B
(iii) Semen analysis in pubertal and adult patients
(iv) Cryopreservation of semen
(v) When considering surgery: testicular biopsy
patients because the gonadotropines may be suppressed due
to elevated adrenal androgens, which are partly aromatized
to estrone and estradiol [43]. In contrast to other causes
of hypogonadotropic, hypogonadism CAH patients have
generally normal or only slightly decreased testosterone
levels because of elevated adrenal androgens. Inhibin B is a
better marker for the evaluation of Sertoli cell function and
may also be used in the evaluation of gonadal function in
prepubertal children [44]. Semen analysis can be performed
in (post) pubertal and adult patients when the patient is
willing to collect semen for analysis.
Because tumour growth may be related to hormonal
control as discussed earlier, it is important to monitor serum
ACTH, renin, 17-hydroxyprogesterone, and androstene-
dione concentrations.
In the case of longstanding tumours in infertile CAH
patients, a testicular biopsy may be helpful to evaluate the
q u a l i t yo fr e s i d u a lt e s t i c u l a rp a r e n c h y m a( s t a g e4o r5 )[ 17].
Such a biopsy is strongly advised before surgical treatment is
oﬀered. However, one should realize that a testicular biopsy
only gives information about a limited area of the testis.
Because only patients in whom aberrant adrenal cells
have been nestled in the testes in the embryological period
are supposed to be at risk for developing TART, it would
be very important to identify these patients as early as
possible. Nowadays, adrenal rests can only be detected after
substantial growth. In our own centre, we start screening
from the age of 8 years old. However, age of screeningInternational Journal of Pediatric Endocrinology 5
Stage 1 Stage 2
Stage 3 Stage 4
Stage 5
Adrenal rest cells present within the rete testis
Rete testis
Seminiferous tubules
Adrenal rest cells
Further growth of the adrenal rest cells 
with compression of the rete testis
Fibrosis within
the tumour
Compression of
the rete testis
Irreversible damage of testicular parenchyma
Peritubular fibrosis
Adipose tissue
within the tumour
Peritubular
hyalinization
Peritubular fibrosis
Fibrosis within 
the tumour
Focal
lymphocytic
infiltrates
Induction of fibrosis and focal 
lymphocytic infiltrates
Hyperplasia and hypertrophy of 
adrenal rest cells
Figure 3: Schematic view of the proposed classiﬁcation of testicular adrenal rests.
in childhood is still controversial because of the limited
experience with treatment options in childhood. In the
future, new sensitive imaging techniques may help to detect
these adrenal rests in the ﬁrst years of life. If this is possible,
patients with adrenal rests within their rete testis could
be monitored and treated more intensively, whereas in
patients without adrenal rests unnecessary ultrasound follow
up and aggressive treatment strategies possibly could be
avoided.
8. Treatment of TART
Until now, intensifying glucocorticoid treatment is the
choice of treatment in patients with TART. Intensifying
glucocorticoid therapy may lead to reduction of the tumour
size by suppression of ACTH secretion thereby improving
testicular function in stages 2 and 3. However, though
case reports with successful pregnancy of partners of male
CAH patients have been published [45], some studies report6 International Journal of Pediatric Endocrinology
Figure 4: Scrotal ultrasound of a 13-year-old male CAH patient.
Transverse image shows a mostly hypoechogenic rounded lesion in
the left testis near the rete testis.
Figure 5: T2-weighted MR image of longstanding bilateral testicu-
lar adrenal rest tumours in a 33-year-old patient. Note that hetero-
geneous low-signal-intensity tumours are displacing surrounding
high signal normal testicular tissue.
failure of intensiﬁed glucocorticoid treatment and serious
side eﬀects after long-standing dexamethasone treatment
and, therefore, some of the patients will not accept this
treatment option [26, 45, 46]. Furthermore, it may be that
this treatment leads only to temporary improvement of
the obstruction because tumour growth may start again
after lowering the glucocorticoid dose. However, optimiz-
ing glucocorticoid medication especially in patients with
poor hormonal control is important to determine whether
tumour growth is reversible (stage 3). Because also AII
may stimulate tumour growth also the mineralocorticoid
suppletion has to be optimized [24].
In stage 4, increasing the dose of glucocorticoids is
probably no longer eﬀective in decreasing tumour size,
but removal of the tumour may prevent further testicular
damage. Because of the benign character of the tumours,
testis-sparing surgery has been proposed for the treatment
of TART. Walker et al. performed testis-sparing surgery in
3 adult CAH patients [25]. Postoperatively, there was good
vascular ﬂow and no recurrence of the tumour. Tiryaki
et al. reported 2 CAH patients with steroid unrespon-
sive testicular tumours, who were also treated by testis-
sparing surgery [47]. In both studies, no information about
pituitary-gonadal function before and after surgery was
reported. In a recent study, we showed that in patients with
longstanding TART (stage 5) gonadal dysfunction did not
improve suggesting irreversible damage of the surrounding
testicular tissue [44]. Furthermore, additional damage from
surgery could not be excluded. From our experience, we now
conclude that in this stage the only indication for surgery is
the relief of pain and discomfort caused by TART. Therefore,
mainly in longstanding TART with signs of gonadal dysfunc-
tion, testicular biopsies are advised to evaluate the quality
of the surrounding testicular parenchyma, before surgery is
considered.
Testicular surgery in CAH children with TART has
not yet been performed. Further studies in childhood are
needed to investigate whether surgery in stages 2, 3, and 4
may prevent irreversible damage to the testes. As long as
medicalandsurgicaltreatmentsofTARTarefarfromperfect,
patients should be informed about the negative eﬀects of
TART on fertility and cryopreservation of semen should be
oﬀered as soon as possible. Because adrenal rest cells are
already present in the embryological period, it is clear that
prevention of TART is not possible.
9. Conclusion
TART is the most important cause of infertility in adult
maleCAHpatients.Theyarenotmalignantbutlongstanding
TART can result in irreversible damage of testicular tissue
and subsequently infertility. TART is also detectable in
children with CAH but the presence of gonadal dysfunction
due to TART in childhood is controversial. TART have
histological and functional features of adrenocortical tissue
and growth can be stimulated by elevated ACTH concen-
trations. Intensifying glucocorticoid therapy is the ﬁrst step
in the treatment of TART. Before testis-sparing surgery is
considered, testicular biopsies are advised to evaluate the
quality of the surrounding testicular parenchyma.
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